Search research articles
Contact Us
Filters
Showing results (141-150 of 168) with videos related to
Page
of 17
Sort By:
The Biochemical Journal
|
October 1, 2013
Mitochondrial fission mediates ceramide-induced metabolic disruption in skeletal muscle
Melissa E Smith, Trevor S Tippetts, Eric S Brassfield, et al.
Clinical Immunology (Orlando, Fla.)
|
May 11, 2024
A novel IKZF1 variant in a family with autosomal dominant CVID: A case for expanding exon coverage in inborn errors of immunity
Ivana Stojkic, Benjamin T Prince, Hye Sun Kuehn, et al.
Blood Cancer Journal
|
September 10, 2013
Induction of high-titer IgG antibodies against multiple leukemia-associated antigens in CML patients with clinical responses to K562/GVAX immunotherapy
L Qin, B D Smith, H-L Tsai, et al.
Diabetology & Metabolic Syndrome
|
November 9, 2012
AICAR inhibits ceramide biosynthesis in skeletal muscle
Katherine A Erickson, Melissa E Smith, Tamil S Anthonymuthu, et al.
Leukemia & Lymphoma
|
April 5, 2022
Genomic landscape of myelodysplastic/myeloproliferative neoplasm can predict response to hypomethylating agent therapy
Theodoros Karantanos, Hua-Ling Tsai, Lukasz P Gondek, et al.
Leukemia & Lymphoma
|
February 15, 2026
Chemotherapy regimens with second generation tyrosine kinase inhibitors for <i>BCR-ABL</i> B-cell acute lymphoblastic leukemia: comparative outcomes and role of allogeneic hematopoietic cell transplantation
John Preston Claiborne, Hua-Ling Tsai, Gabriel Ghiaur, et al.
Leukemia & Lymphoma
|
February 6, 2023
Venetoclax in combination with hypomethylating agent for the treatment of advanced myeloproliferative neoplasms and acute myeloid leukemia with extramedullary disease
Khaled Sanber, Kevin Ye, Hua-Ling Tsai, et al.
The Journal of Heredity
|
November 29, 2015
Phylogeography, Genetic Diversity, and Management Units of Hawksbill Turtles in the Indo-Pacific
Sarah M Vargas, Michael P Jensen, Simon Y W Ho, et al.
Oncotarget
|
February 8, 2019
Imbalanced sphingolipid signaling is maintained as a core proponent of a cancerous phenotype in spite of metabolic pressure and epigenetic drift
Monique M P Speirs, Adam C Swensen, Tsz Y Chan, et al.
Leukemia Research
|
September 17, 2025
Efficacy and safety of blinatumomab for CD19 + acute leukemias in patients historically excluded from clinical trials due to comorbidities
J Preston Claiborne, Daniel Li, Hua-Ling Tsai, et al.
Page
of 17
Search research articles
Search
Showing results (141-150 of 168) with videos related to
Sort By:
Page
of 17
The Biochemical Journal
|
October 1, 2013
Mitochondrial fission mediates ceramide-induced metabolic disruption in skeletal muscle
Melissa E Smith, Trevor S Tippetts, Eric S Brassfield, et al.
Clinical Immunology (Orlando, Fla.)
|
May 11, 2024
A novel IKZF1 variant in a family with autosomal dominant CVID: A case for expanding exon coverage in inborn errors of immunity
Ivana Stojkic, Benjamin T Prince, Hye Sun Kuehn, et al.
Blood Cancer Journal
|
September 10, 2013
Induction of high-titer IgG antibodies against multiple leukemia-associated antigens in CML patients with clinical responses to K562/GVAX immunotherapy
L Qin, B D Smith, H-L Tsai, et al.
Diabetology & Metabolic Syndrome
|
November 9, 2012
AICAR inhibits ceramide biosynthesis in skeletal muscle
Katherine A Erickson, Melissa E Smith, Tamil S Anthonymuthu, et al.
Leukemia & Lymphoma
|
April 5, 2022
Genomic landscape of myelodysplastic/myeloproliferative neoplasm can predict response to hypomethylating agent therapy
Theodoros Karantanos, Hua-Ling Tsai, Lukasz P Gondek, et al.
Leukemia & Lymphoma
|
February 15, 2026
Chemotherapy regimens with second generation tyrosine kinase inhibitors for <i>BCR-ABL</i> B-cell acute lymphoblastic leukemia: comparative outcomes and role of allogeneic hematopoietic cell transplantation
John Preston Claiborne, Hua-Ling Tsai, Gabriel Ghiaur, et al.
Leukemia & Lymphoma
|
February 6, 2023
Venetoclax in combination with hypomethylating agent for the treatment of advanced myeloproliferative neoplasms and acute myeloid leukemia with extramedullary disease
Khaled Sanber, Kevin Ye, Hua-Ling Tsai, et al.
The Journal of Heredity
|
November 29, 2015
Phylogeography, Genetic Diversity, and Management Units of Hawksbill Turtles in the Indo-Pacific
Sarah M Vargas, Michael P Jensen, Simon Y W Ho, et al.
Oncotarget
|
February 8, 2019
Imbalanced sphingolipid signaling is maintained as a core proponent of a cancerous phenotype in spite of metabolic pressure and epigenetic drift
Monique M P Speirs, Adam C Swensen, Tsz Y Chan, et al.
Leukemia Research
|
September 17, 2025
Efficacy and safety of blinatumomab for CD19 + acute leukemias in patients historically excluded from clinical trials due to comorbidities
J Preston Claiborne, Daniel Li, Hua-Ling Tsai, et al.
Page
of 17